Ribociclib as a Potential Multi-Target Inhibitor of Pro-Inflammatory Cytokines: An In Silico Investigation
This paper investigates Ribociclib's interactions with pro-inflammatory cytokines using computational methods, finding it forms stable complexes with several cytokines and may act as a multi-target anti-inflammatory agent.
bioRxiv · Feb 7, 2026 · PreprintPharmacology & Toxicology